Cvs Health (CVS) Non-Current Deferred Tax Liability (2016 - 2025)
Cvs Health (CVS) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $11.4 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deferred Tax Liability changed 0.48% year-over-year to $11.4 billion, compared with a TTM value of $11.4 billion through Dec 2025, changed 0.48%, and an annual FY2025 reading of $11.4 billion, changed 0.48% over the prior year.
- Non-Current Deferred Tax Liability was $11.4 billion for Q4 2025 at Cvs Health, up from $3.5 billion in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $11.4 billion in Q4 2024 and bottomed at $3.5 billion in Q3 2022.
- Average Non-Current Deferred Tax Liability over 5 years is $5.4 billion, with a median of $4.3 billion recorded in 2023.
- The sharpest move saw Non-Current Deferred Tax Liability crashed 44.57% in 2022, then skyrocketed 164.74% in 2024.
- Year by year, Non-Current Deferred Tax Liability stood at $6.3 billion in 2021, then crashed by 35.95% to $4.0 billion in 2022, then increased by 7.35% to $4.3 billion in 2023, then surged by 164.74% to $11.4 billion in 2024, then decreased by 0.48% to $11.4 billion in 2025.
- Business Quant data shows Non-Current Deferred Tax Liability for CVS at $11.4 billion in Q4 2025, $3.5 billion in Q3 2025, and $3.6 billion in Q2 2025.